Johnson & Johnson (NYSE:JNJ) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...
Seeking Alpha17d
What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular Therapies
Johnson & Johnson (NYSE ... and the acquisition adds an important commercial product for a growth-starved big pharma company like J&J, and I think that the early-stage pipeline could bring upside ...